Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Supplier dossier · §5

TFC — correspondence log

Every enquiry the Institute made, why it made it, and the outcome, including enquiries that received no answer.

Document identifier
CEI-SD-09/5
Series
Supplier dossier
Version
1.3
Published
25 Apr 2024
Last reviewed
25 Sep 2024
Next review
25 Sep 2025
Identifier
10.71829/cei.supp.9
Certainty
Not rated
Cycle
2024 Q2
Assessment score
75.0 / 100
Conformance
B

The Institute assesses documentation, not product. It has purchased nothing, tested nothing and inspected nothing. Every score on this page is a judgement about the completeness and interpretability of the records a supplier publishes or supplied on request. A high score means that a supplier documents its material well. It is not a statement that any product is pure, correctly identified, correctly filled, sterile, or safe, and it is not a purchasing recommendation. The Institute makes no purchasing recommendations.

§5Correspondence log

The Institute records every enquiry it makes to a supplier and the outcome of each, including enquiries that received no answer. A dossier that reports only the information a supplier chose to supply presents the supplier's disclosure decision as the Institute's assessment.

§5.1Enquiry log

Table 3. Correspondence between the Institute and TFC, in date order.

SentSubjectWhy the Institute askedOutcomeDays to reply
30 Apr 2023Request for aggregate determination by size-exclusion chromatographyA reverse-phase purity method is blind to aggregation.Declined21
30 Jun 2023Request for stability data supporting a stated in-use periodAn in-use claim requires a stability-indicating method applied to the actual presentation.Declined24
08 Nov 2023Request for the chromatographic method underlying a reported purity figureA purity percentage without its method is not comparable with any other purity percentage.No response within the standing period
13 Feb 2024Request for the scope of a claimed accreditationAccreditation is granted for named tests within a defined scope.No response within the standing period
20 Apr 2024Request for endotoxin data on a presentation intended for injectionEndotoxin is the attribute least often measured and among those most likely to matter.Acknowledged, no substantive response40
11 Jul 2024Request for an orthogonal identity confirmationRetention-time correspondence alone does not distinguish a deletion sequence or a stereochemical variant.Acknowledged, no substantive response32
07 Nov 2024Request for the integration window used in a reported determinationChanging the window changes the reported purity without changing the material.Answered in part32
21 Mar 2025Notification of a factual correction to the dossierThe Institute notifies a supplier of a correction before publishing it.Answered in part40
01 May 2025Request for the integration window used in a reported determinationChanging the window changes the reported purity without changing the material.No response within the standing period
9 enquiries recorded. Correspondence was conducted by the Institute's secretariat in writing. The Institute holds no telephone contact and uses no messaging channel.

§5.2Right of reply

Tianjin Finder Chemical Co., Ltd. was sent this dossier in draft and given twenty-eight days to respond before publication. A response is published in the supplier's own words where one is received. The Institute corrects errors of fact on evidence and does not alter a judgement because a supplier disagrees with it; a disagreement is published alongside the judgement so that a reader can weigh both.[1]

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.